{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T21:40:24Z","timestamp":1791754824037,"version":"4.3.4"},"reference-count":106,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,22]],"date-time":"2024-08-22T00:00:00Z","timestamp":1724284800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007186","name":"UCLA JCCC","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007186","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007185","name":"University of California, Los Angeles","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007185","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012640","name":"Alan B Slifka Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012640","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["U24CA248265"],"award-info":[{"award-number":["U24CA248265"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA244729-03S1"],"award-info":[{"award-number":["R01CA244729-03S1"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Stem Cell"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.stem.2024.08.010","type":"journal-article","created":{"date-parts":[[2024,9,20]],"date-time":"2024-09-20T10:38:52Z","timestamp":1726828732000},"page":"1524-1542.e4","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":70,"title":["The landscape of drug sensitivity and resistance in sarcoma"],"prefix":"10.1016","volume":"31","author":[{"given":"Ahmad","family":"Al Shihabi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peyton J.","family":"Tebon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huyen Thi Lam","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jomjit","family":"Chantharasamee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Sartini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ardalan","family":"Davarifar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra Y.","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miranda","family":"Diaz-Infante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Cox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfredo Enrique","family":"Gonzalez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Summer","family":"Norris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jantzen","family":"Sperry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Nakashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nasrin","family":"Tavanaie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"Winata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sorel T.","family":"Fitz-Gibbon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takafumi N.","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae H.","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Dry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arun S.","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bartosz","family":"Chmielowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph G.","family":"Crompton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anusha K.","family":"Kalbasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fritz C.","family":"Eilber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis","family":"Hornicek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas M.","family":"Bernthal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott D.","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul C.","family":"Boutros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noah C.","family":"Federman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane","family":"Yanagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6634-2885","authenticated-orcid":false,"given":"Alice","family":"Soragni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.stem.2024.08.010_bib1","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S1535-6108(02)00132-0","article-title":"Focus on sarcomas","volume":"2","author":"Mackall","year":"2002","journal-title":"Cancer Cell"},{"key":"10.1016\/j.stem.2024.08.010_bib2","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1002\/1097-0142(19950101)75:1+<395::AID-CNCR2820751321>3.0.CO;2-W","article-title":"Childhood cancer","volume":"75","author":"Miller","year":"1995","journal-title":"Cancer"},{"key":"10.1016\/j.stem.2024.08.010_bib3","first-page":"7","article-title":"Cancer statistics, 2022","volume":"72","author":"Siegel","year":"2022","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.stem.2024.08.010_bib4","doi-asserted-by":"crossref","first-page":"815","DOI":"10.6004\/jnccn.2022.0035","article-title":"Soft tissue sarcoma, version 2.2022, NCCN clinical practice guidelines in oncology","volume":"20","author":"von Mehren","year":"2022","journal-title":"J.\u00a0Natl. Compr. Canc. Netw."},{"key":"10.1016\/j.stem.2024.08.010_bib6","series-title":"SEER Cancer Statistics Review (CSR) 1975-2017","year":"2020"},{"key":"10.1016\/j.stem.2024.08.010_bib7","doi-asserted-by":"crossref","first-page":"99","DOI":"10.3390\/jmp4020011","article-title":"Different Subtypes of Osteosarcoma: Histopathological Patterns and Clinical Behaviour","volume":"4","author":"Rothzerg","year":"2023","journal-title":"J.\u00a0Mol. Pathol."},{"key":"10.1016\/j.stem.2024.08.010_bib8","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1146\/annurev-cancerbio-030518-055710","article-title":"Biology and Therapy of Dominant Fusion Oncoproteins Involving Transcription Factor and Chromatin Regulators in Sarcomas","volume":"3","author":"Perry","year":"2019","journal-title":"Annu. Rev. Cancer Biol."},{"key":"10.1016\/j.stem.2024.08.010_bib9","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/s41392-021-00647-8","article-title":"Molecular mechanisms underpinning sarcomas and implications for current and future therapy","volume":"6","author":"Damerell","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.stem.2024.08.010_bib10","doi-asserted-by":"crossref","first-page":"3405","DOI":"10.1038\/s41467-022-30453-x","article-title":"Clinical sequencing of soft tissue and bone sarcomas delineates diverse genomic landscapes and potential therapeutic targets","volume":"13","author":"Nacev","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.stem.2024.08.010_bib11","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.ccell.2019.02.002","article-title":"Undifferentiated Sarcomas Develop through Distinct Evolutionary Pathways","volume":"35","author":"Steele","year":"2019","journal-title":"Cancer Cell"},{"key":"10.1016\/j.stem.2024.08.010_bib12","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/nrc3087","article-title":"Advances in sarcoma genomics and new therapeutic targets","volume":"11","author":"Taylor","year":"2011","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.stem.2024.08.010_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1200\/PO.18.00247","article-title":"Precision Oncology in Sarcomas: Divide and Conquer","volume":"3","author":"Carmagnani Pestana","year":"2019","journal-title":"JCO Precis. Oncol."},{"key":"10.1016\/j.stem.2024.08.010_bib14","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1038\/s41379-020-0488-1","article-title":"A novel next generation sequencing approach to improve sarcoma diagnosis","volume":"33","author":"McConnell","year":"2020","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.stem.2024.08.010_bib15","doi-asserted-by":"crossref","first-page":"489","DOI":"10.3389\/fonc.2020.00489","article-title":"Next-Generation Sequencing Approaches for the Identification of Pathognomonic Fusion Transcripts in Sarcomas: The Experience of the Italian ACC Sarcoma Working Group","volume":"10","author":"Racanelli","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.stem.2024.08.010_bib16","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1093\/jnci\/djz245","article-title":"The Molecular Analysis for Therapy Choice (NCI-MATCH) Trial: Lessons for Genomic Trial Design","volume":"112","author":"Flaherty","year":"2020","journal-title":"J.\u00a0Natl. Cancer Inst."},{"key":"10.1016\/j.stem.2024.08.010_bib105","doi-asserted-by":"crossref","first-page":"3406","DOI":"10.1038\/s41467-022-30496-0","article-title":"Clinical genomic profiling in the management of patients with soft tissue and bone sarcoma","volume":"13","author":"Gounder","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.stem.2024.08.010_bib17","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1001\/jamaoncol.2018.0723","article-title":"Targetable Alterations in Adult Patients With Soft-Tissue Sarcomas: Insights for Personalized Therapy","volume":"4","author":"Lucchesi","year":"2018","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.stem.2024.08.010_bib18","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.semcancer.2022.05.011","article-title":"Biology-guided precision medicine in rare cancers: Lessons from sarcomas and neuroendocrine tumours","volume":"84","author":"van der Graaf","year":"2022","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.stem.2024.08.010_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.xpro.2020.100056","article-title":"Patient-Derived Tumor Organoid Rings for Histologic Characterization and High-Throughput Screening","volume":"1","author":"Nguyen","year":"2020","journal-title":"Star Protoc."},{"key":"10.1016\/j.stem.2024.08.010_bib20","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1126\/science.aao2774","article-title":"Patient-derived organoids model treatment response of metastatic gastrointestinal cancers","volume":"359","author":"Vlachogiannis","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.stem.2024.08.010_bib21","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.1158\/0008-5472.CAN-21-4128","article-title":"Colorectal Cancer Develops Inherent Radiosensitivity That Can Be Predicted Using Patient-Derived Organoids","volume":"82","author":"Hsu","year":"2022","journal-title":"Cancer Res."},{"key":"10.1016\/j.stem.2024.08.010_bib22","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.cell.2015.03.053","article-title":"Prospective Derivation of a Living Organoid Biobank of Colorectal Cancer Patients","volume":"161","author":"van de Wetering","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.stem.2024.08.010_bib23","doi-asserted-by":"crossref","first-page":"5376","DOI":"10.1158\/1078-0432.CCR-18-3590","article-title":"Patient-Derived Cancer Organoid Cultures to Predict Sensitivity to Chemotherapy and Radiation","volume":"25","author":"Pasch","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.stem.2024.08.010_bib24","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aay2574","article-title":"Patient-derived organoids can predict response to chemotherapy in metastatic colorectal cancer patients","volume":"11","author":"Ooft","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.stem.2024.08.010_bib25","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.stem.2019.10.010","article-title":"Patient-Derived Organoids Predict Chemoradiation Responses of Locally Advanced Rectal Cancer","volume":"26","author":"Yao","year":"2020","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.stem.2024.08.010_bib26","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1158\/2159-8290.CD-18-0349","article-title":"Organoid Profiling Identifies Common Responders to Chemotherapy in Pancreatic Cancer","volume":"8","author":"Tiriac","year":"2018","journal-title":"Cancer Discov."},{"key":"10.1016\/j.stem.2024.08.010_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s43586-022-00174-y","article-title":"Organoids","volume":"2","author":"Zhao","year":"2022","journal-title":"Nat. Rev. Methods Primers"},{"key":"10.1016\/j.stem.2024.08.010_bib28","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abl3674","article-title":"Personalized chordoma organoids for drug discovery studies","volume":"8","author":"Al Shihabi","year":"2022","journal-title":"Sci. Adv."},{"key":"10.1016\/j.stem.2024.08.010_bib29","doi-asserted-by":"crossref","first-page":"7354","DOI":"10.1245\/s10434-022-12086-y","article-title":"Patient-Specific Sarcoma Organoids for Personalized Translational Research: Unification of the Operating Room with Rare Cancer Research and Clinical Implications","volume":"29","author":"Forsythe","year":"2022","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.stem.2024.08.010_bib106","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s12032-020-01429-y","article-title":"Organoid culture system for patient-derived lung metastatic osteosarcoma","volume":"37","author":"He","year":"2020","journal-title":"Med. Oncol."},{"key":"10.1016\/j.stem.2024.08.010_bib30","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/s42003-019-0305-x","article-title":"A simple high-throughput approach identifies actionable drug sensitivities in patient-derived tumor organoids","volume":"2","author":"Phan","year":"2019","journal-title":"Commun. Biol."},{"key":"10.1016\/j.stem.2024.08.010_bib31","doi-asserted-by":"crossref","first-page":"3168","DOI":"10.1038\/s41467-023-38832-8","article-title":"Drug screening at single-organoid resolution via bioprinting and interferometry","volume":"14","author":"Tebon","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.stem.2024.08.010_bib32","article-title":"A platform for rapid patient-derived cutaneous neurofibroma organoid establishment and screening","volume":"4","author":"Nguyen","year":"2024","journal-title":"Cell Rep. Methods"},{"key":"10.1016\/j.stem.2024.08.010_bib33","series-title":"Medical Image Computing and Computer-Assisted Intervention\u00a0\u2013 MICCAI 2015 Lecture Notes in Computer Science.","first-page":"234","article-title":"U-Net: Convolutional Networks for Biomedical Image Segmentation","author":"Ronneberger","year":"2015"},{"key":"10.1016\/j.stem.2024.08.010_bib34","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1177\/1087057105285610","article-title":"A Comparison of Assay Performance Measures in Screening Assays: Signal Window, Z\u2019 Factor, and Assay Variability Ratio","volume":"11","author":"Iversen","year":"2006","journal-title":"J.\u00a0Biomol. Screen."},{"key":"10.1016\/j.stem.2024.08.010_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneumeth.2020.108699","article-title":"Adaptation of robust Z\u2019 factor for assay quality assessment in microelectrode array based screening using adult dorsal root ganglion neurons","volume":"339","author":"Atmaramani","year":"2020","journal-title":"J.\u00a0Neurosci. Methods"},{"key":"10.1016\/j.stem.2024.08.010_bib36","doi-asserted-by":"crossref","first-page":"3662","DOI":"10.1158\/1078-0432.CCR-20-0073","article-title":"Medium-throughput drug screening of patient-derived organoids from colorectal peritoneal metastases to direct personalized therapy","volume":"26","author":"Narasimhan","year":"2020","journal-title":"Clin. Cancer Res. Off."},{"key":"10.1016\/j.stem.2024.08.010_bib37","series-title":"The MD Anderson Manual of Medical Oncology","article-title":"Targeted Therapy in Cancer","author":"Said","year":"2022"},{"key":"10.1016\/j.stem.2024.08.010_bib38","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1007\/s11060-010-0441-0","article-title":"The role of chemotherapy in pediatric clival chordomas","volume":"103","author":"Dhall","year":"2011","journal-title":"J.\u00a0Neurooncol."},{"key":"10.1016\/j.stem.2024.08.010_bib39","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1634\/theoncologist.2007-0237","article-title":"The Clinical Approach Towards Chondrosarcoma","volume":"13","author":"Gelderblom","year":"2008","journal-title":"Oncologist"},{"key":"10.1016\/j.stem.2024.08.010_bib40","doi-asserted-by":"crossref","first-page":"7801","DOI":"10.1002\/cam4.5539","article-title":"Patterns of care and outcome of CIC-rearranged sarcoma patients: A nationwide study of the French sarcoma group","volume":"12","author":"Brahmi","year":"2023","journal-title":"Cancer Med."},{"key":"10.1016\/j.stem.2024.08.010_bib41","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2022.40.16_suppl.11553","article-title":"A phase 1 dose-escalation\/expansion clinical trial of mocetinostat in combination with vinorelbine in adolescents and young adults with refractory and\/or recurrent rhabdomyosarcoma: Interim results","volume":"40","author":"Federman","year":"2022","journal-title":"JCO"},{"key":"10.1016\/j.stem.2024.08.010_bib42","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.201911131","article-title":"Sarcoma treatment in the era of molecular medicine","volume":"12","author":"Gr\u00fcnewald","year":"2020","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.stem.2024.08.010_bib43","doi-asserted-by":"crossref","first-page":"e71","DOI":"10.1016\/S1470-2045(14)71190-8","article-title":"Building a global consensus approach to chordoma: a position paper from the medical and patient community","volume":"16","author":"Stacchiotti","year":"2015","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.stem.2024.08.010_bib44","doi-asserted-by":"crossref","first-page":"e69","DOI":"10.1016\/S1470-2045(11)70337-0","article-title":"Chordoma: current concepts, management, and future directions","volume":"13","author":"Walcott","year":"2012","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.stem.2024.08.010_bib45","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1042\/BJ20061088","article-title":"BI-D1870 is a specific inhibitor of the p90 RSK (ribosomal S6 kinase) isoforms in\u00a0vitro and in\u00a0vivo","volume":"401","author":"Sapkota","year":"2007","journal-title":"Biochem. J."},{"key":"10.1016\/j.stem.2024.08.010_bib46","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/00000421-200008000-00009","article-title":"Phase II Trial of Topotecan in Patients With Advanced, Persistent, or Recurrent Uterine Leiomyosarcomas: A Gynecologic Oncology Group Study","volume":"23","author":"Miller","year":"2000","journal-title":"Am. J. Clin. Oncol."},{"key":"10.1016\/j.stem.2024.08.010_bib47","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.semradonc.2009.09.003","article-title":"Sarcomas Across the Age Spectrum","volume":"20","author":"Wolden","year":"2010","journal-title":"Semin. Radiat. Oncol."},{"key":"10.1016\/j.stem.2024.08.010_bib48","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3747\/co.27.5475","article-title":"Update on Systemic Therapy for Advanced Soft-Tissue Sarcoma","volume":"27","author":"Smrke","year":"2020","journal-title":"Curr. Oncol."},{"key":"10.1016\/j.stem.2024.08.010_bib49","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1038\/s41467-021-27889-y","article-title":"Age influences on the molecular presentation of tumours","volume":"13","author":"Li","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.stem.2024.08.010_bib50","doi-asserted-by":"crossref","first-page":"D613","DOI":"10.1093\/nar\/gkaa1024","article-title":"WikiPathways: connecting communities","volume":"49","author":"Martens","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.stem.2024.08.010_bib51","doi-asserted-by":"crossref","first-page":"D587","DOI":"10.1093\/nar\/gkac963","article-title":"KEGG for taxonomy-based analysis of pathways and genomes","volume":"51","author":"Kanehisa","year":"2023","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.stem.2024.08.010_bib52","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s12944-019-0977-8","article-title":"Changes in lipids composition and metabolism in colorectal cancer: a review","volume":"18","author":"Pakiet","year":"2019","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.stem.2024.08.010_bib53","doi-asserted-by":"crossref","first-page":"3296","DOI":"10.1158\/1078-0432.CCR-21-4165","article-title":"Precision medicine in pancreatic cancer: Patient derived organoid pharmacotyping is a predictive biomarker of clinical treatment response","volume":"28","author":"Sepp\u00e4l\u00e4","year":"2022","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.stem.2024.08.010_bib54","doi-asserted-by":"crossref","first-page":"3049","DOI":"10.1016\/j.apsb.2022.02.002","article-title":"Why 90% of clinical drug development fails and how to improve it?","volume":"12","author":"Sun","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.stem.2024.08.010_bib55","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/s41572-022-00409-y","article-title":"Osteosarcoma","volume":"8","author":"Beird","year":"2022","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.stem.2024.08.010_bib56","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.stem.2024.08.010_bib57","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/S1470-2045(14)71136-2","article-title":"Sorafenib and everolimus for patients with unresectable high-grade osteosarcoma progressing after standard treatment: a non-randomised phase 2 clinical trial","volume":"16","author":"Grignani","year":"2015","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.stem.2024.08.010_bib58","doi-asserted-by":"crossref","first-page":"5341","DOI":"10.1158\/0008-5472.CAN-15-1654","article-title":"Identification of Variant-Specific Functions of PIK3CA by Rapid Phenotyping of Rare Mutations","volume":"75","author":"Dogruluk","year":"2015","journal-title":"Cancer Res."},{"key":"10.1016\/j.stem.2024.08.010_bib59","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1200\/JCO.2017.72.7107","article-title":"Phosphatidylinositol 3-Kinase \u03b1-Selective Inhibition With Alpelisib (BYL719) in PIK3CA-Altered Solid Tumors: Results From the First-in-Human Study","volume":"36","author":"Juric","year":"2018","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.stem.2024.08.010_bib60","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3892\/or.2022.8295","article-title":"In\u00a0vitro anticancer effects of alpelisib against PIK3CA-mutated canine hemangiosarcoma cell lines","volume":"47","author":"Maeda","year":"2022","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.stem.2024.08.010_bib61","doi-asserted-by":"crossref","DOI":"10.1001\/jamaoncol.2018.4475","article-title":"Alpelisib Plus Fulvestrant in PIK3CA-Altered and PIK3CA-Wild-Type Estrogen Receptor\u2013Positive Advanced Breast Cancer: A Phase 1b Clinical Trial","volume":"5","author":"Juric","year":"2019","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.stem.2024.08.010_bib62","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1056\/NEJMoa1813904","article-title":"Alpelisib for PIK3CA-Mutated, Hormone Receptor\u2013Positive Advanced Breast Cancer","volume":"380","author":"Andr\u00e9","year":"2019","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.stem.2024.08.010_bib63","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/s41379-018-0118-3","article-title":"Molecular characterization of cancers with NTRK gene fusions","volume":"32","author":"Gatalica","year":"2019","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.stem.2024.08.010_bib64","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1177\/1093526617712639","article-title":"Infantile NTRK-associated Mesenchymal Tumors","volume":"21","author":"Davis","year":"2018","journal-title":"Pediatr. Dev. Pathol."},{"key":"10.1016\/j.stem.2024.08.010_bib65","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/ng0298-184","article-title":"A novel ETV6-NTRK3 gene fusion in congenital fibrosarcoma","volume":"18","author":"Knezevich","year":"1998","journal-title":"Nat. Genet."},{"key":"10.1016\/j.stem.2024.08.010_bib66","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1097\/00000478-200007000-00005","article-title":"Molecular Detection of the ETV6-NTRK3 Gene Fusion Differentiates Congenital Fibrosarcoma From Other Childhood Spindle Cell Tumors","volume":"24","author":"Bourgeois","year":"2000","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.stem.2024.08.010_bib67","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S1470-2045(18)30119-0","article-title":"Larotrectinib for paediatric solid tumours harbouring NTRK gene fusions: phase 1 results from a multicentre, open-label, phase 1\/2 study","volume":"19","author":"Laetsch","year":"2018","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.stem.2024.08.010_bib68","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1023\/A:1008221713505","article-title":"Long-term follow-up and post-relapse survival in patients with non-metastatic osteosarcoma of the extremity treated with neoadjuvant chemotherapy","volume":"8","author":"Ferrari","year":"1997","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.stem.2024.08.010_bib69","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.3390\/cancers12082311","article-title":"Time to Next Treatment as a Meaningful Endpoint for Trials of Primary Cutaneous Lymphoma","volume":"12","author":"Campbell","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.stem.2024.08.010_bib70","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1479-5876-6-23","article-title":"Identification of heterogeneity among soft tissue sarcomas by gene expression profiles from different tumors","volume":"6","author":"Skubitz","year":"2008","journal-title":"J.\u00a0Transl. Med."},{"key":"10.1016\/j.stem.2024.08.010_bib71","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/s43018-022-00337-6","article-title":"A human breast cancer-derived xenograft and organoid platform for drug discovery and precision oncology","volume":"3","author":"Guillen","year":"2022","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.stem.2024.08.010_bib72","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1158\/2159-8290.CD-17-0151","article-title":"AACR Project GENIE: Powering Precision Medicine through an International Consortium","volume":"7","year":"2017","journal-title":"Cancer Discov."},{"key":"10.1016\/j.stem.2024.08.010_bib73","doi-asserted-by":"crossref","first-page":"525","DOI":"10.3390\/cancers14030525","article-title":"Pancreatic Cancer Organoids in the Field of Precision Medicine: A Review of Literature and Experience on Drug Sensitivity Testing with Multiple Readouts and Synergy Scoring","volume":"14","author":"M\u00e4kinen","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.stem.2024.08.010_bib74","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1302\/0301-620X.102B6.BJJ-2019-1307.R1","article-title":"Impact of chemotherapy-induced necrosis on event-free and overall survival after preoperative MAP chemotherapy in patients with primary high-grade localized osteosarcoma","volume":"102-B","author":"Tsuda","year":"2020","journal-title":"Bone Joint. J."},{"key":"10.1016\/j.stem.2024.08.010_bib75","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2023.100823","article-title":"43P Time to next treatment (TTNT) of first-line maintenance (1Lm) niraparib monotherapy in epithelial ovarian cancer (EOC) patients (pts) in the CHAR1ZMA study","volume":"8","author":"Coleman","year":"2023","journal-title":"ESMO Open"},{"key":"10.1016\/j.stem.2024.08.010_bib76","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1200\/CCI.20.00125","article-title":"Comparisons of Real-World Time-to-Event End Points in Oncology Research","volume":"5","author":"Walker","year":"2021","journal-title":"JCO Clin. Cancer Inform."},{"key":"10.1016\/j.stem.2024.08.010_bib107","unstructured":"ClinicalTrials.gov. An organoid-based functional precision medicine trial in osteosarcoma. https:\/\/clinicaltrials.gov\/study\/NCT06064682."},{"key":"10.1016\/j.stem.2024.08.010_bib77","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.tranon.2019.12.001","article-title":"Pazopanib in the Treatment of Bone Sarcomas: Clinical Experience","volume":"13","author":"Aggerholm-Pedersen","year":"2020","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.stem.2024.08.010_bib78","doi-asserted-by":"crossref","first-page":"3044","DOI":"10.3390\/cancers13123044","article-title":"Soft Tissue Sarcoma: An Insight on Biomarkers at Molecular, Metabolic and Cellular Level","volume":"13","author":"Pillozzi","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.stem.2024.08.010_bib79","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1634\/theoncologist.13-S2-32","article-title":"Selection of Response Criteria for Clinical Trials of Sarcoma Treatment","volume":"13","author":"Schuetze","year":"2008","journal-title":"Oncologist"},{"key":"10.1016\/j.stem.2024.08.010_bib80","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/5784876","article-title":"Targeting Refractory Sarcomas and Malignant Peripheral Nerve Sheath Tumors in a Phase I\/II Study of Sirolimus in Combination with Ganetespib (SARC023)","volume":"2020","author":"Kim","year":"2020","journal-title":"Sarcoma"},{"key":"10.1016\/j.stem.2024.08.010_bib81","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1158\/1078-0432.CCR-11-2139","article-title":"18F-FDG-PET\/CT Imaging as an Early Survival Predictor in Patients with Primary High-Grade Soft Tissue Sarcomas Undergoing Neoadjuvant Therapy","volume":"18","author":"Herrmann","year":"2012","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.stem.2024.08.010_bib82","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1148\/radiol.2015142463","article-title":"Multiparametric Assessment of Treatment Response in High-Grade Soft-Tissue Sarcomas with Anatomic and Functional MR Imaging Sequences","volume":"278","author":"Soldatos","year":"2016","journal-title":"Radiology"},{"key":"10.1016\/j.stem.2024.08.010_bib83","unstructured":"American Cancer Society. Cancer Facts\u00a0& Figures\u00a02024. https:\/\/www.cancer.org\/research\/cancer-facts-statistics\/all-cancer-facts-figures\/2024-cancer-facts-figures.html."},{"key":"10.1016\/j.stem.2024.08.010_bib84","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0246958","article-title":"Nationwide incidence of sarcomas and connective tissue tumors of intermediate malignancy over four years using an expert pathology review network","volume":"16","author":"de Pinieux","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.stem.2024.08.010_bib85","doi-asserted-by":"crossref","first-page":"751","DOI":"10.5858\/arpa.2016-0527-OA","article-title":"Validation of OncoPanel: A Targeted Next-Generation Sequencing Assay for the Detection of Somatic Variants in Cancer","volume":"141","author":"Garcia","year":"2017","journal-title":"Arch. Pathol. Lab. Med."},{"key":"10.1016\/j.stem.2024.08.010_bib86","article-title":"Efficient Architecture-Aware Acceleration of BWA-MEM for Multicore Systems","author":"Vasimuddin","year":"2019","journal-title":"arXiv"},{"key":"10.1016\/j.stem.2024.08.010_bib87","doi-asserted-by":"crossref","DOI":"10.1093\/gigascience\/giab008","article-title":"Twelve years of SAMtools and BCFtools","volume":"10","author":"Danecek","year":"2021","journal-title":"GigaScience"},{"key":"10.1016\/j.stem.2024.08.010_bib88","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1101\/gr.107524.110","article-title":"The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing data","volume":"20","author":"McKenna","year":"2010","journal-title":"Genome Res."},{"key":"10.1016\/j.stem.2024.08.010_bib89","article-title":"Calling Somatic SNVs and Indels with Mutect2","author":"Benjamin","year":"2019","journal-title":"bioRxiv"},{"key":"10.1016\/j.stem.2024.08.010_bib90","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1186\/s13059-016-1029-6","article-title":"MuSE: accounting for tumor heterogeneity using a sample-specific error model improves sensitivity and specificity in mutation calling from sequencing data","volume":"17","author":"Fan","year":"2016","journal-title":"Genome Biol."},{"key":"10.1016\/j.stem.2024.08.010_bib91","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1093\/bioinformatics\/btr665","article-title":"SomaticSniper: identification of somatic point mutations in whole genome sequencing data","volume":"28","author":"Larson","year":"2012","journal-title":"Bioinformatics"},{"key":"10.1016\/j.stem.2024.08.010_bib92","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/s41592-018-0051-x","article-title":"Strelka2: fast and accurate calling of germline and somatic variants","volume":"15","author":"Kim","year":"2018","journal-title":"Nat. Methods"},{"key":"10.1016\/j.stem.2024.08.010_bib93","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1016\/j.cell.2012.04.023","article-title":"The Life History of 21 Breast Cancers","volume":"149","author":"Nik-Zainal","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.stem.2024.08.010_bib94","doi-asserted-by":"crossref","first-page":"16910","DOI":"10.1073\/pnas.1009843107","article-title":"Allele-specific copy number analysis of tumors","volume":"107","author":"Van Loo","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.stem.2024.08.010_bib95","doi-asserted-by":"crossref","DOI":"10.1093\/bioinformatics\/btae081","article-title":"NFTest: automated testing of Nextflow pipelines","volume":"40","author":"Patel","year":"2024","journal-title":"Bioinformatics"},{"key":"10.1016\/j.stem.2024.08.010_bib96","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1038\/nbt.3820","article-title":"Nextflow enables reproducible computational workflows","volume":"35","author":"Di Tommaso","year":"2017","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.stem.2024.08.010_bib97","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1000529","article-title":"A Flexible and Accurate Genotype Imputation Method for the Next Generation of Genome-Wide Association Studies","volume":"5","author":"Howie","year":"2009","journal-title":"PLoS Genet."},{"key":"10.1016\/j.stem.2024.08.010_bib98","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","article-title":"STAR: ultrafast universal RNA-seq aligner","volume":"29","author":"Dobin","year":"2013","journal-title":"Bioinformatics."},{"key":"10.1016\/j.stem.2024.08.010_bib99","series-title":"PartekTM Genomics SuiteTM, [Version 7.0]","year":"2024"},{"key":"10.1016\/j.stem.2024.08.010_bib100","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol."},{"key":"10.1016\/j.stem.2024.08.010_bib101","doi-asserted-by":"crossref","first-page":"D1388","DOI":"10.1093\/nar\/gkaa971","article-title":"PubChem in 2021: new data content and improved web interfaces","volume":"49","author":"Kim","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.stem.2024.08.010_bib102","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1177\/108705719900400206","article-title":"A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays","volume":"4","author":"Zhang","year":"1999","journal-title":"J.\u00a0Biomol. Screen."},{"key":"10.1016\/j.stem.2024.08.010_bib103","series-title":"2016 IEEE Conference on Computer Vision and Pattern Recognition (CVPR)","first-page":"770","article-title":"Deep Residual Learning for Image Recognition","author":"He","year":"2016"},{"key":"10.1016\/j.stem.2024.08.010_bib104","series-title":"2009 IEEE Conference on Computer Vision and Pattern Recognition","first-page":"248","article-title":"ImageNet: A large-scale hierarchical image database","author":"Deng","year":"2009"}],"container-title":["Cell Stem Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1934590924002960?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1934590924002960?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T08:22:26Z","timestamp":1778833346000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1934590924002960"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":106,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["S1934590924002960"],"URL":"https:\/\/doi.org\/10.1016\/j.stem.2024.08.010","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2023.05.25.542375","asserted-by":"object"}]},"ISSN":["1934-5909"],"issn-type":[{"value":"1934-5909","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The landscape of drug sensitivity and resistance in sarcoma","name":"articletitle","label":"Article Title"},{"value":"Cell Stem Cell","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.stem.2024.08.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}